EPIGRAL
vs
B
BSE Sensex 30
EPIGRAL
Over the past 12 months, EPIGRAL has underperformed BSE Sensex 30, delivering a return of -43% compared to the BSE Sensex 30's +11% growth.
Stocks Performance
EPIGRAL vs BSE Sensex 30
Performance Gap
EPIGRAL vs BSE Sensex 30
Performance By Year
EPIGRAL vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Epigral Ltd
Glance View
Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.
